Filing Details
- Accession Number:
- 0001104659-23-023901
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-21 18:54:58
- Reporting Period:
- 2023-02-16
- Accepted Time:
- 2023-02-21 18:54:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609550 | Inspire Medical Systems Inc. | INSP | Surgical & Medical Instruments & Apparatus (3841) | 261377674 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1662781 | Philip Ebeling | C/O Inspire Medical Systems, Inc. 5500 Wayzata Blvd., Suite 1600 Golden Valley MN 55416 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-16 | 7,000 | $194.82 | 7,243 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-16 | 7,000 | $275.00 | 243 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2023-02-16 | 7,000 | $0.00 | 7,000 | $194.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,300 | 2030-12-14 | No | 4 | M | Direct |
Footnotes
- The option has vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
Billionaire Hedge Funds
